Insulin is a well-established target of the autoimmune response in T1D, and it has been hypothesized that early insulin administration may delay disease onset by allowing β-cells to rest and reducing T-cell infiltration into the pancreatic islets [333]. This evidence concerns the gene INS and type 1 diabetes mellitus.